Pfizer Inc
May 17, 2012 at 07:16 | Source: Reuters
Apr 18, 2012 at 06:46 | Source: Reuters
Apr 05, 2012 at 10:45 | Source: PTI
Mar 21, 2012 at 03:52 | Source: Reuters
Jan 06, 2012 at 15:08 | Source: None
Dec 07, 2011 at 09:50 | Source: Moneycontrol.com
News across the web »
May 23, 2012 at 00:12 | Source: DNA India
May 22, 2012 at 22:01 | Source: Wall Street Journal
May 21, 2012 at 02:00 | Source: Bloomberg
May 18, 2012 at 04:00 | Source: Bloomberg
May 18, 2012 at 04:00 | Source: Business Week
Interact & exchange stock tips & market info »
Related News »
HONG KONG--(Marketwire -05/25/12)- This morning, www.MarketFoundations.com announced new reports highlighting Pfizer Inc. (PFE) and Alcoa Inc. (AA). Free research downloads are available at www.MarketFoundations.com/index.php?coa=PFE&cob=AA.
May 25, 2012 at 12:57 | Source: Yahoo Finance
A Food and Drug Administration advisory panel said a clinical study submitted by Pfizer Inc. (>> Pfizer Inc.) for a drug to treat a rare genetic disorder that affects the nervous system contains enough information for the FDA to consider approving the drug.
May 24, 2012 at 20:44 | Source: 4-traders (press release)
May 24 (Reuters) - Pfizer Inc said a U.S. health advisory panel voted against its drug to treat a rare neurodegenerative disease as the data did not show enough evidence of efficacy. The panel's recommendation will be considered by the U.S Food ...
May 24, 2012 at 22:46 | Source: Reuters
(RTTNews) - Pfizer Inc. (PFE: News ) announced Thursday that the United States Food and Drug Administration's or FDA Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine. Tafamidis ...
May 24, 2012 at 22:17 | Source: RTT News
(Reuters) - A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease. The U.S. Food and Drug Administration panel voted 13 to 4 that the drug did not show that it met the main goal ...
May 25, 2012 at 04:36 | Source: YAHOO!
Pfizer Inc. (NYSE: PFE) named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012. He will succeed David Simmons, who is leaving Pfizer to become the ...
May 23, 2012 at 15:16 | Source: Genetic Engineering News
May 25, 2012 (Close-Up Media via COMTEX News Network) -- Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Pfizer's oncology leadership team at an analyst and investor meeting on Sunday, June 3 ...
May 25, 2012 at 04:51 | Source: comcast.net
Pfizer Inc. (>> Pfizer Inc.) recently recalled more than 650,000 bottles of Advil pain-relief medicine due to the potential for a strong odor in the product. New York-based Pfizer issued the voluntary recall of eight lots of Advil Liqui-Gels bottles in ...
May 18, 2012 at 17:02 | Source: 4-traders (press release)
WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff reviewed the pill ...
May 22, 2012 at 14:34 | Source: msnbc.com
(RTTNews.com) - Pfizer, Inc. (PFE) said the Committee for Human Medicinal Products, or CHMP, of the European Medicines Agency has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union for the ...
May 25, 2012 at 13:26 | Source: NASDAQ